Inventor profile of:

Daniel C. Maneval

City:

San Diego, California

Country:

United States

Published Applications:

30

Last publication date:

2019-03-21

Top Assignees for applications by Daniel C. Maneval

The entities that hold a legal rights for patent applications filed by inventor Maneval Daniel C.:

Recent patent applications by Maneval Daniel C.

Daniel C. Maneval from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-03-21
US20190083449A1
Human necessities

COMBINATION THERAPY WITH AN ANTI-HYALURONAN AGENT AND THERAPEUTIC AGENT

#2 | 2017-10-12
US20170290796A1
Human necessities

Combination therapy with an anti-hyaluronan agent and therapeutic agent

#3 | 2013-11-14
US20130302400A1
Human necessities

Combination therapy with an anti-hyaluronan agent and therapeutic agent

#4 | 2011-05-05
US20110104118A1
Human necessities

COMPOSITIONS AND METHODS FOR THERAPEUTIC USE

#5 | 2009-04-02
US20090088398A1
Chemistry; metallurgy

RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE

#6 | 2009-03-26
US20090082289A1
Chemistry; metallurgy

Adenoviral vectors having a protein IX deletion

#7 | 2009-02-19
US20090048148A1
Human necessities

COMPOSITIONS AND METHODS FOR THERAPEUTIC USE

#8 | 2008-12-04
US20080299083A1
Chemistry; metallurgy

Adenoviral vectors having a protein IX deletion

#9 | 2008-11-20
US20080286239A1
Chemistry; metallurgy

COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS

#10 | 2008-07-31
US20080182807A1
Chemistry; metallurgy

Adenoviral vectors having a protein IX deletion

#11 | 2008-07-24
US20080175818A1
Chemistry; metallurgy

ADENOVIRAL VECTORS HAVING A PROTEIN IX DELETION

#12 | 2007-11-01
US20070253932A1
Chemistry; metallurgy

RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE

#13 | 2007-06-07
US20070128166A1
Chemistry; metallurgy

Adenoviral vectors having a protein IX deletion

#14 | 2007-05-31
US20070122379A1
Human necessities

COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS

#15 | 2007-02-08
US20070031381A1
Chemistry; metallurgy

Recombinant adenoviral vector and method of use

#16 | 2007-01-18
US20070014768A1
Human necessities

Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

#17 | 2007-01-11
US20070009486A1
Chemistry; metallurgy

Adenoviral vectors having a protein IX deletion

#18 | 2007-01-11
US20070009485A1
Chemistry; metallurgy

Nucleic acid delivery

#19 | 2006-12-07
US20060275261A1
Human necessities

Adenoviral vectors having a protein IX deletion

#20 | 2006-10-19
US20060233759A1
Human necessities

Adenoviral vectors having a protein IX deletion

#21 | 2006-09-12
US8472760
-

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

#22 | 2006-08-03
US20060171925A1
Human necessities

Adenoviral vectors having a protein IX deletion

#23 | 2006-06-29
US20060140910A1
Chemistry; metallurgy

Recombinant adenoviral vectors and methods of use

#24 | 2006-05-11
US20060099187A1
Human necessities

Adenoviral vectors having a protein IX deletion

#25 | 2006-05-09
US8958570
-

Recombinant adenoviral vector and method of use

#26 | 2006-02-23
US20060039893A1
Chemistry; metallurgy

Adenoviral vectors having a protein IX deletion

#27 | 2006-02-16
US20060034804A1
Chemistry; metallurgy

Adenoviral vectors having a protein IX deletion

#28 | 2006-01-24
US10441510
-

Recombinant adenoviral vector and methods of use

#29 | 2005-06-30
US20050142112A1
Human necessities

Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

#30 | 2005-01-20
US20050014259A1
Chemistry; metallurgy

Nucleic acid delivery

InventorID:

528445 ⎘